Delivery Order SPE2DB24D1205-SPE2DB25FCZFB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,546.29 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $7,401.38 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,238.54 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication. The contract, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive procurement. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,117.20 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes management medication. This competitively awarded, firm fixed-price contract was executed on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract carries no set-aside designation and represents a discrete order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a $1,942.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for 90 tablets of Januvia 100 mg, a diabetes management medication. This non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes medication, with a ceiling value of $46.7K. The contract, which was not set-aside and competitively awarded, carries a firm fixed price structure and an ultimate completion date of August 14, 2025. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania facility, serving as a critical pharmaceutical supply source for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $36,390.38 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 25, 2025, with completion scheduled for July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the prime contractor. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $15,238.68 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, with a completion date of July 24, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside arrangement. The award was processed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 pharmaceutical supply vehicle...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,452.56 for 1,000 tablets of Januvia 100 mg on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract is a firm fixed price, non-set-aside delivery order issued by the Defense Department's Medical Supply Chain organization. Performance will be conducted at the company's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply delivery under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,025.75 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of July 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery. This delivery order operates...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZFBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $20,394.12 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and was competitively awarded without any set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor with an extensive portfolio of competitive contract awards for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.4k | 8/4/25 |